It is not often that one is able to bear witness to a sea change. The veterinary community has, in my opinion, seen one with the development of the melanoma vaccine. This unique form of therapy, a DNA-based vaccine, would justify my opinion, but the successful collaboration between veterinary oncologists, human oncologists and the pharmaceutical industry also serve to mark this event as extraordinary.